LigaSure in total thyroidectomy. by Cipolla, C. et al.
Surg Today (2008) 38:495–498
DOI 10.1007/s00595-007-3665-7
Reprint requests to: C. Cipolla, Via Pietro Di Novo 5, 90018 
Termini Imerese (PA), Italy
Received: October 5, 2006 / Accepted: March 9, 2007
LigaSure in Total Thyroidectomy
CALOGERO CIPOLLA, GIUSEPPA GRACEFFA, LUIGI SANDONATO, SALVATORE FRICANO, SALVATORE VIENI, 
and MARIO A. LATTERI
Department of Oncology, Division of General and Oncological Surgery, University of Palermo, AOU Policlinico Paolo Giaccone, 
Palermo, Italy
Abstract
Purpose. LigaSure is a bipolar diathermy system, which 
achieves vessel sealing with reduced thermal spread. 
The device has been used successfully in abdominal 
operations and because of its features, it has been 
applied recently in thyroid surgery to minimize the risk 
of complications such as laryngeal nerve palsy and 
hypocalcemia, and also to reduce the operating time.
Methods. Between June and December 2005, we per-
formed total thyroidectomy for various disorders in 105 
patients. We used the LigaSure diathermy system in 53 
patients and traditional hemostatic procedures in the 
other 52. We evaluated the demographic features, his-
topathological diagnosis, operating times, and relevant 
postoperative complications.
Results. The two study groups had similar demographic 
and histopathological features. The mean operating 
time ± SD was not signifi cantly shorter in the LigaSure 
group than in the traditional group (104 ± 12.7 vs 110 ± 
15.6 min). None of the patients in either group suffered 
hemorrhage, defi nitive hypocalcemia, or defi nitive 
laryngeal nerve palsy. Transient hypocalcemia and tran-
sient laryngeal nerve palsy developed in 7.54% and in 
1.88%, respectively, of the patients in the LigaSure 
group, and in 7.69% and 1.92%, respectively, of the 
patients in the traditional group; these differences were 
not signifi cant.
Conclusions. LigaSure is a safe and effective method of 
hemostasis control, but it did not reduce the incidence 
of complications or operating times compared with tra-
ditional hemostatic procedures; moreover, the opera-
tive costs were higher.
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Introduction
Thyroidectomy is one of the most frequently performed 
operations in the fi eld of general surgery. It involves 
meticulous devascularization of the thyroid gland, which 
has one of the richest blood supplies of all organs. The 
gold standard for intraoperative hemostasis in thyroid 
surgery is suture ligation with bipolar or monopolar 
electrocoagulation for smaller vessels.1 However, the 
use of electrocoagulation to control bleeding carries 
 a risk of damage to the surrounding structures because 
of the lateral heat dispersion.2 Recently, several alterna-
tive methods of hemostasis, such as the harmonic scalpel 
and laser techniques, have been tested in thyroid surgery 
with encouraging results,3–6 but few reports have been 
published on LigaSure in this fi eld.
Apart from its hemostatic effi ciency and safety, Liga-
Sure may minimize the risk of damage to the parathy-
roid glands and to the recurrent laryngeal nerve, because 
it disperses less heat to the surrounding tissue than 
classic bipolar or monopolar electrocoagulation 
methods. We conducted this study to compare LigaSure 
with traditional hemostatic procedures in total thyroid-
ectomy, focusing on operating times and potential rele-
vant postoperative complications. In our experience, 
total thyroidectomy is the treatment of choice, not only 
for thyroid carcinoma, but for most benign thyroid dis-
eases, because it prevents disease relapse and the need 
for repeated surgery with its related higher rate of 
complications.
Patients and Methods
The subjects of this study were 105 patients who under-
went total thyroidectomy in our surgical department 
between June and December 2005. Exclusion criteria 
included diseases involving the vocal cords, secondary 
thyroid surgery, previous operations on the neck, and 
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the need for lymph node dissection. All patients had 
preoperative workup consisting of clinical examination, 
thyroid ultrasound and scintigraphy, cytological sam-
pling with fi ne-needle aspiration, thyroid hormone 
assay, and optic fi ber laryngoscopy to observe vocal 
cord motility. The same surgical team operated on all 
patients. Total thyroidectomy is indicated when an 
increase in glandular volume causes compressive symp-
toms, when drug therapy has proved unsatisfactory, and 
above all, for chronic thyroiditis with suspected neo-
plastic degeneration of one or more nodules.
Patients were divided into two groups according to 
the method of hemostasis used during total thyroidec-
tomy: LigaSure (n = 53) or traditional hemostatic 
methods of knot-tying and bipolar electrocoagulation 
(n = 52). The basis of the study and the surgical proce-
dures were explained to each patient, whose inclusion 
in one group or the other was based on their choice, 
age, and on the preoperative diagnostic assessment, 
with the aim of obtaining two relatively homogeneous 
groups for the most accurate results possible. Standard 
total thyroidectomy was performed in all patients. After 
a skin collar incision, subplatysmal fl aps were prepared 
and the strap muscles were divided along the midline 
until the thyroid gland was exposed and dislocated. The 
upper, middle, and lower vascular peduncles were then 
isolated and sectioned, with the smaller vascular struc-
tures in the ligament of Berry. During this procedure, 
extreme care was taken to identify and safeguard the 
recurrent laryngeal nerves and the parathyroid glands; 
furthermore, in the LigaSure group, manual ligatures 
were inserted if the point of the instrument was in 
contact with the recurrent nerves or the parathyroid 
glands. At the conclusion of thyroidectomy, the opera-
tive fi eld was irrigated and a small closed suction drain-
age tube was inserted. The strap muscles were then 
drawn together with absorbable, 2-0 interrupted sutures; 
the platysma and the subcutaneous tissue were sutured 
with absorbable, 3-0 interrupted sutures; and skin 
closure was done with non-absorbable 3-0 subcutaneous 
sutures. These latter stitches were removed on postop-
erative day (POD) 10.
The operating time was defi ned as the time from the 
skin incision to the fi nal suture in skin closure. Hypo-
parathyroidism was diagnosed by clinical symptoms 
requiring replacement therapy of calcium and vitamin 
D, after diagnostic confi rmation by an assay of serum 
values of calcemia and phosphatemia. All patients were 
followed up 30 days after surgery, with optic fi ber laryn-
goscopy, to assess vocal cord function. Both hypothy-
roidism and recurrent palsy were considered permanent 
if they had not resolved 6 months after surgery. Statisti-
cal analysis was done by the χ2 test, with Yates’ correc-
tion where appropriate.
Results
The 53 patients in the LigaSure group consisted of 10 
men and 43 women, ranging in age from 27 to 77 years 
(mean 50.1 ± 11.4 years), while the 52 patients in the 
traditional group consisted of 9 men and 43 women, 
ranging in age from 17 to 75 years (mean 50.5 ± 14.3 
years).
The histopathological diagnoses were as follows: nor-
mofunctional multinodular goiter in 33 patients from 
the LigaSure group and 31 from the traditional group; 
hyperfunctional nodular goiter in 4 patients from the 
LigaSure group and 5 from the traditional group; 
Graves’ disease in 3 patients from the LigaSure patients 
and 2 from the traditional group; autoimmune lympho-
cytic thyroiditis in 8 patients from the LigaSure group 
and 8 from the traditional group; and differentiated 
carcinoma of the thyroid in 5 patients from the LigaSure 
group and 6 from the traditional group (Table 1).
The mean operating times were 104 ± 12.7 min (range 
80–145 min) in the LigaSure group and 110 ± 15.6 min 
(range 85–135 min) in the traditional group, without a 
signifi cant difference. The reduction in mean operating 
time when the LigaSure was used instead of traditional 
methods of hemostasis was only 6 min. The mean intra-
operative blood loss was 58 ± 38.2 ml (range 35–115 ml) 
in the LigaSure group and 61 ± 37.5 ml (range 35–125 ml) 
in the traditional group, without a signifi cant difference. 
Table 1. Demographic and histopathological features of the patients undergoing total 
thyroidectomy with LigaSure or traditional hemostatic methods
LigaSure group Traditional group
Age (years) 22–77 17–75
mean 50.1 ± 11.4 mean 50.5 ± 14.3
M/F 10/43 9/43
Normofunctional multinodular goiter 33 31
Hyperfunctional multinodular goiter 4 5
Graves’ disease 3 2
Autoimmune lymphocytic thyroiditis 8 8
Differentiated thyroid carcinoma 5 6
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In both groups, the suction drainage was removed on 
postoperative day (POD) 1. The mean drainage output 
was 89 ± 12.4 ml (range 55–125 ml) in the LigaSure 
group and 86 ± 12.6 ml (range 50–105 ml) in the tradi-
tional group, without signifi cance.
There were no signifi cant differences between the 
two groups in the weight of the excised thyroid gland 
at histopathological examination or in the incidence of 
postoperative complications. None of the patients in 
either group required reoperation for bleeding, and 
none suffered permanent hypoparathyroidism or recur-
rent palsy. Transient recurrent palsy developed in one 
(1.9%) patient from the LigaSure group and one (1.9%) 
from the traditional group. Symptomatic transient 
hypoparathyroidism was confi rmed by low serum levels 
of calcium in four (7.5%) patients from the LigaSure 
group and four (7.7%) from the traditional group, 
without signifi cance (Table 2). All patients were dis-
charged from hospital on POD 2.
Discussion
Total thyroidectomy is the treatment of choice for many 
thyroid diseases. This operation is performed frequently 
in regions such as ours, where goiter is an endemic 
disease, and many affected people seek surgical treat-
ment only after the goiter has become voluminous. 
As with any surgical procedure, the surgeon tries to 
minimize the risk of complications and to ensure that 
the operation proceeds as smoothly and rapidly as 
possible.
For some time, LigaSure has been used successfully 
in numerous abdominal, urological, and gynecological 
operations and many clinical studies have confi rmed its 
effi ciency and safety; not only for achieving hemostasis, 
but also for reducing the operating time, particularly in 
laparoscopic procedures.3–7 The LigaSure vessel sealing 
system, developed by Valleylab (Boulder, CO, USA), 
is a hemostatic method offering a consistent permanent 
autologous seal to veins, arteries, and tissue bundles of 
up to 7 mm in diameter. It consists of an electrosurgical 
generator and a handpiece with a ratcheted scissor 
mechanism. When the tissue is grasped and compressed 
by the instrument, the response generator senses the 
density of the tissue bundle, and the generator com-
puter automatically adjusts the amount of energy to be 
delivered. This form of energy denatures collagen and 
elastin within the vessel wall and surrounding connec-
tive tissue. The added strong pressure applied by the 
instrument causes the denatured collagen and elastin to 
reform with the vessel walls in apposition. When sealing 
is complete, the microprocessor-controlled feedback 
automatically terminates the pulse. After the instru-
ment is removed, the seal is visible as a translucent seal 
zone, which can be safely divided.8–10 Sealing is achieved 
with minimal sticking and charring; thus, a limited 
amount of energy is delivered, resulting in a minimal 
thermal spread to adjacent tissues, of approximately 0.5 
to 2 mm.11
Since the effective hemostasis and limited heat spread 
may prevent damage to the parathyroid glands and the 
recurrent laryngeal nerve, the use of LigaSure has 
recently been extended to thyroid surgery. This is also 
due to the commercial availability of a much small 
handpiece (16.5 cm) than those used in abdominal 
surgery. However, the reported results of using LigaS-
ure in thyroid surgery have been fairly discordant. 
Several authors reported a reduction in complications 
such as transient recurrent palsy and transient hypo-
parathyroidism and shorter operating times,12 whereas 
others reported a shorter operating time but no change 
in the incidence of complications.13–15 Some authors 
even reported no difference in operating times or the 
incidence of complications between LigaSure and tradi-
tional hemostatic methods.16
Table 2. Operating times, weight of the thyroid gland, intraoperative blood loss, drain-
age volume, and complications in the two groups
LigaSure group Traditional group P
Operating time (min) 80–145 85–135 NS
mean 104 ± 12.7 mean 110 ± 15.6
Gland weight (g) 40–205 45–220 NS
mean 117 ± 36.8 120 ± 36.1
Intraoperative blood loss (ml) 35–115 35–125 NS
58 ± 38.2 61 ± 37.5
Drainage volume (ml) 55–125 50–105 NS
mean 89 ± 12.4 mean 86 ± 12.6
Hemorrhage 0 0 NS
Defi nitive hypoparathyroidism 0 0 NS
Transient hypoparathyroidism 4 (7.5%) 4 (7.7%) NS
Defi nitive laryngeal nerve palsy 0 0 NS
Transient laryngeal nerve palsy 1 (1.9%) 1 (1.9%) NS
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We began using LigaSure in thyroidectomy in 2002. 
In our previous series of 67 total thyroidectomies per-
formed with LigaSure, we reported only a slightly lower 
incidence of complications than that in 579 total thy-
roidectomies performed with traditional hemostatic 
techniques.17 Because our fi rst experience with LigaS-
ure convinced us that the method was simple, easy to 
learn, and technically straightforward, we decided to 
verify our initial results by conducting a comparative 
prospective study of patients scheduled to undergo total 
thyroidectomy. After obtaining informed consent, 105 
patients were enrolled in the study and divided into two 
groups according to whether the LigaSure method or 
traditional hemostatic suturing and bipolar electroco-
agulation was used. We then compared the incidence of 
complications and operating times between the two 
methods. Our analysis confi rmed that LigaSure was an 
effective, safe, and easy-to-use hemostatic method, but 
there were no signifi cant differences in the incidence 
of severe complications or operating times between the 
two methods. Moreover, we found that although the 
ligature of the upper and of the lower thyroid vessels 
seemed to be easier than and at least as fast as conven-
tional knot-tying, meticulous ligation of the numerous 
small vessels with LigaSure was not as easy because of 
the size of the instrument tip, which was too large to use 
on such small vessels. In accordance with several other 
reports,16 we do not think that the LigaSure method is 
suitable for the precise surgical maneuvers required for 
operations in the vicinity of extremely delicate struc-
tures such as the recurrent nerves. Furthermore, the 
method is not very precise or reliable for the coagula-
tion of tiny thyroid vessels. In fact, we had to ligate the 
tiny vessels by hand in our patients who underwent total 
thyroidectomy with the LigaSure method when the tip 
of the handpiece was in contact with the recurrent 
nerves or the parathyroid glands.
Several authors14,15 maintain that LigaSure is suitable 
for use in hemithyroidectomy, since it makes separating 
the thyroid gland tissue easier than traditional methods 
of ligation, thereby reducing the operating time to about 
20 min. We do agree that the device may be faster and 
more effi cient in the early phases of the operation: for 
coagulating the external jugular veins, for preparing 
fl aps by separating the platysma, and for separating the 
strap muscles along the linea alba.
A fi nal consideration concerns the high cost of the 
device: about 18 000 c for the generator and 600 c for 
the scissor mechanism. In this regard, the cost/benefi t 
ratio of a thyroidectomy performed with the LigaSure 
method is not as good as that of a thyroidectomy per-
formed with traditional hemostatic techniques.
In conclusion, although LigaSure is without doubt an 
extremely effi cient and safe hemostatic method for use 
in thyroidectomy, it does not ensure a lower incidence 
of complications or shorter operating times and it is 
very expensive. Thus, we conclude that the LigaSure 
method does not offer any real advantage over tradi-
tional methods of hemostasis in total thyroidectomy.
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